You are here: Industry Insights > Novartis

News List

IFM Therapeutics and Novartis Complete Previously Announced Acquisition of IFM Tre firstwordpharma
May 09, 2019
IFM Therapeutics (IFM), a privately-held biopharmaceutical company focused on developing therapies that modulate novel targets in the innate immune system ...
Novartis to acquire Takeda's dry eye treatment Xiidra in a deal valued at up to $5.3 billion firstwordpharma
May 09, 2019
Novartis on Wednesday announced that it has reached an agreement to purchase the assets associated with Takeda's dry eye treatment Xiidra (lifitegrast). In the deal,
Haseeb Ahmad has been named as the new president of ABPI europeanpharmaceuticalreview
May 09, 2019
Haseeb Ahmad from Novartis Pharmaceuticals has been confirmed as the new president of the The Association of the British Pharmaceutical Industry (ABPI).
Novartis presents first-of-its-kind algorithm-based tool to help MS patients and physicians worldpharmanews
May 08, 2019
Novartis presents first-of-its-kind algorithm-based tool to help MS patients and physicians.
Novartis to globally co-commercialise Amgen’s migraine drug europeanpharmaceuticalreview
May 07, 2019
Novartis has expanded their commercialisation agreement with Amgen for AMG 334 (erenumab), which is being investigated for the prevention of migraine…
Novartis & Bristol-Myers Squibb to collaborate on cancer treatments europeanpharmaceuticalreview
May 07, 2019
Novartis has entered into a research collaboration in which Bristol-Myers Squibb will investigate the safety, tolerability, and efficacy of Mekinist…
Cosentyx, Entresto again drive growth at Novartis. But what about the future of Zolgensma? fiercepharma
April 25, 2019
The future of Novartis’ potential blockbuster spinal muscular atrophy gene therapy Zolgensma has come under question, what with a recent child death reported in the company's European trial.
Novartis nabs GSK executive for Sandoz CEO, bringing in a familiar face—and some digital prowess fiercepharma
April 25, 2019
Novartis is transforming Sandoz into an autonomous unit within the larger company.
Novartis launches global assessment of media buying and planning duties fiercepharma
April 25, 2019
Novartis is reviewing media buying and planning in a global evaluation of its agency partners.
Novartis recruits GSK exec as new Sandoz CEO pharmatimes
April 25, 2019
Novartis has announced that GlaxoSmithKline’s current vice president of classic and established products, commercial and digital platforms has joined the company as chief executive of its Sandoz unit.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 71 72 Next page